Industry Research Reports

Part 1

Part 2

Part 3

Part 4

Part 5

Home > Reports > Service & Software > Pharmacokinetics Software - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Pharmacokinetics Software - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Industry: Service & Software

Published: 2025-11-27

Pages: 120 Pages

Report ld: 5490584

Request Sample

Pre-Order Enquiry

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description

The global market for Pharmacokinetics Software was estimated to be worth US$ 476 million in 2024 and is forecast to a readjusted size of US$ 846 million by 2031 with a CAGR of 8.2% during the forecast period 2025-2031.

Pharmacokinetics Software is a type of professional software developed based on pharmacokinetic theory and computer algorithms. It is specifically used to process data related to the absorption, distribution, metabolism and excretion of drugs in organisms, and to realize functions such as parameter calculation, model building and process simulation. It provides data support and decision-making basis for drug development, clinical trials and personalized medicine.

Pharmacokinetics Software Market Size(US$)

M= millions and B=billions

North America still dominates the global market, but the Asia-Pacific market is emerging at a faster growth rate. In 2023, North America was the largest revenue market in the field of pharmacokinetic computational biology, and in the life sciences software market, North America accounted for 42% of the market share in 2024, thanks to its mature innovative drug development system and the strong demand from numerous CRO companies.

Policy adjustments by global regulatory agencies are continuously reshaping the development direction of pharmacokinetic software. The FDA's updated guidance in 2023 explicitly requires innovative drug applications to include physiologically based pharmacokinetic (PBPK) model data, and the EMA plans to implement an electronic submission system for ePK files by 2026. These policies are compelling pharmaceutical companies to adopt software with stronger compliance and better data management capabilities.

This report aims to provide a comprehensive presentation of the global market for Pharmacokinetics Software, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Pharmacokinetics Software by region & country, by Type, and by Application.

The Pharmacokinetics Software market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmacokinetics Software.

Market Segmentation

Report Metric
Details
Report Title
Pharmacokinetics Software - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Forecasted Market Size in 2031
US$ 846 million
CAGR(2025-2031)
8.2%
Market Size Available for Years
2025-2031
Global Pharmacokinetics Software Companies Covered
Certara
Simulations Plus
IntiQuan GmbH
Bayer
Genedata AG
Thermo Scientific
SGS
Pharmaron
Pumas-AI
PharmoGo
Chuangteng Technology
Medixi Biomedical
Global Pharmacokinetics Software Market, by Region
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Pharmacokinetics Software Market, Segment by Type
Compartmental Model
Non-Compartmental Models
Global Pharmacokinetics Software Market, Segment by Application
Experimental Design
Clinical Pharmacokinetics
Other
Product Category
Drug Development
Clinical
Academic Teaching
Market Segment
Cloud-Based
On-premises
Forecast Units
Million USD
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Pharmacokinetics Software company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Pharmacokinetics Software in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Pharmacokinetics Software in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

1 Market Overview
    1.1 Pharmacokinetics Software Product Introduction
    1.2 Global Pharmacokinetics Software Market Size Forecast (2020-2031)
    1.3 Pharmacokinetics Software Market Trends & Drivers
        1.3.1 Pharmacokinetics Software Industry Trends
        1.3.2 Pharmacokinetics Software Market Drivers & Opportunity
        1.3.3 Pharmacokinetics Software Market Challenges
        1.3.4 Pharmacokinetics Software Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

2 Competitive Analysis by Company
    2.1 Global Pharmacokinetics Software Players Revenue Ranking (2024)
    2.2 Global Pharmacokinetics Software Revenue by Company (2020-2025)
    2.3 Key Companies Pharmacokinetics Software Manufacturing Base Distribution and Headquarters
    2.4 Key Companies Pharmacokinetics Software Product Offered
    2.5 Key Companies Time to Begin Mass Production of Pharmacokinetics Software
    2.6 Pharmacokinetics Software Market Competitive Analysis
        2.6.1 Pharmacokinetics Software Market Concentration Rate (2020-2025)
        2.6.2 Global 5 and 10 Largest Companies by Pharmacokinetics Software Revenue in 2024
        2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmacokinetics Software as of 2024)
    2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Compartmental Model
        3.1.2 Non-Compartmental Models
    3.2 Global Pharmacokinetics Software Sales Value by Type
        3.2.1 Global Pharmacokinetics Software Sales Value by Type (2020 VS 2024 VS 2031)
        3.2.2 Global Pharmacokinetics Software Sales Value, by Type (2020-2031)
        3.2.3 Global Pharmacokinetics Software Sales Value, by Type (%) (2020-2031)

4 Segmentation by Scene
    4.1 Introduction by Scene
        4.1.1 Drug Development
        4.1.2 Clinical
        4.1.3 Academic Teaching
    4.2 Global Pharmacokinetics Software Sales Value by Scene
        4.2.1 Global Pharmacokinetics Software Sales Value by Scene (2020 VS 2024 VS 2031)
        4.2.2 Global Pharmacokinetics Software Sales Value, by Scene (2020-2031)
        4.2.3 Global Pharmacokinetics Software Sales Value, by Scene (%) (2020-2031)

5 Segmentation by Deployment
    5.1 Introduction by Deployment
        5.1.1 Cloud-Based
        5.1.2 On-premises
    5.2 Global Pharmacokinetics Software Sales Value by Deployment
        5.2.1 Global Pharmacokinetics Software Sales Value by Deployment (2020 VS 2024 VS 2031)
        5.2.2 Global Pharmacokinetics Software Sales Value, by Deployment (2020-2031)
        5.2.3 Global Pharmacokinetics Software Sales Value, by Deployment (%) (2020-2031)

6 Segmentation by Application
    6.1 Introduction by Application
        6.1.1 Experimental Design
        6.1.2 Clinical Pharmacokinetics
        6.1.3 Other
    6.2 Global Pharmacokinetics Software Sales Value by Application
        6.2.1 Global Pharmacokinetics Software Sales Value by Application (2020 VS 2024 VS 2031)
        6.2.2 Global Pharmacokinetics Software Sales Value, by Application (2020-2031)
        6.2.3 Global Pharmacokinetics Software Sales Value, by Application (%) (2020-2031)

7 Segmentation by Region
    7.1 Global Pharmacokinetics Software Sales Value by Region
        7.1.1 Global Pharmacokinetics Software Sales Value by Region: 2020 VS 2024 VS 2031
        7.1.2 Global Pharmacokinetics Software Sales Value by Region (2020-2025)
        7.1.3 Global Pharmacokinetics Software Sales Value by Region (2026-2031)
        7.1.4 Global Pharmacokinetics Software Sales Value by Region (%), (2020-2031)
    7.2 North America
        7.2.1 North America Pharmacokinetics Software Sales Value, 2020-2031
        7.2.2 North America Pharmacokinetics Software Sales Value by Country (%), 2024 VS 2031
    7.3 Europe
        7.3.1 Europe Pharmacokinetics Software Sales Value, 2020-2031
        7.3.2 Europe Pharmacokinetics Software Sales Value by Country (%), 2024 VS 2031
    7.4 Asia Pacific
        7.4.1 Asia Pacific Pharmacokinetics Software Sales Value, 2020-2031
        7.4.2 Asia Pacific Pharmacokinetics Software Sales Value by Region (%), 2024 VS 2031
    7.5 South America
        7.5.1 South America Pharmacokinetics Software Sales Value, 2020-2031
        7.5.2 South America Pharmacokinetics Software Sales Value by Country (%), 2024 VS 2031
    7.6 Middle East & Africa
        7.6.1 Middle East & Africa Pharmacokinetics Software Sales Value, 2020-2031
        7.6.2 Middle East & Africa Pharmacokinetics Software Sales Value by Country (%), 2024 VS 2031

8 Segmentation by Key Countries/Regions
    8.1 Key Countries/Regions Pharmacokinetics Software Sales Value Growth Trends, 2020 VS 2024 VS 2031
    8.2 Key Countries/Regions Pharmacokinetics Software Sales Value, 2020-2031
    8.3 United States
        8.3.1 United States Pharmacokinetics Software Sales Value, 2020-2031
        8.3.2 United States Pharmacokinetics Software Sales Value by Type (%), 2024 VS 2031
        8.3.3 United States Pharmacokinetics Software Sales Value by Application, 2024 VS 2031
    8.4 Europe
        8.4.1 Europe Pharmacokinetics Software Sales Value, 2020-2031
        8.4.2 Europe Pharmacokinetics Software Sales Value by Type (%), 2024 VS 2031
        8.4.3 Europe Pharmacokinetics Software Sales Value by Application, 2024 VS 2031
    8.5 China
        8.5.1 China Pharmacokinetics Software Sales Value, 2020-2031
        8.5.2 China Pharmacokinetics Software Sales Value by Type (%), 2024 VS 2031
        8.5.3 China Pharmacokinetics Software Sales Value by Application, 2024 VS 2031
    8.6 Japan
        8.6.1 Japan Pharmacokinetics Software Sales Value, 2020-2031
        8.6.2 Japan Pharmacokinetics Software Sales Value by Type (%), 2024 VS 2031
        8.6.3 Japan Pharmacokinetics Software Sales Value by Application, 2024 VS 2031
    8.7 South Korea
        8.7.1 South Korea Pharmacokinetics Software Sales Value, 2020-2031
        8.7.2 South Korea Pharmacokinetics Software Sales Value by Type (%), 2024 VS 2031
        8.7.3 South Korea Pharmacokinetics Software Sales Value by Application, 2024 VS 2031
    8.8 Southeast Asia
        8.8.1 Southeast Asia Pharmacokinetics Software Sales Value, 2020-2031
        8.8.2 Southeast Asia Pharmacokinetics Software Sales Value by Type (%), 2024 VS 2031
        8.8.3 Southeast Asia Pharmacokinetics Software Sales Value by Application, 2024 VS 2031
    8.9 India
        8.9.1 India Pharmacokinetics Software Sales Value, 2020-2031
        8.9.2 India Pharmacokinetics Software Sales Value by Type (%), 2024 VS 2031
        8.9.3 India Pharmacokinetics Software Sales Value by Application, 2024 VS 2031

9 Company Profiles
    9.1 Certara
        9.1.1 Certara Profile
        9.1.2 Certara Main Business
        9.1.3 Certara Pharmacokinetics Software Products, Services and Solutions
        9.1.4 Certara Pharmacokinetics Software Revenue (US$ Million) & (2020-2025)
        9.1.5 Certara Recent Developments
    9.2 Simulations Plus
        9.2.1 Simulations Plus Profile
        9.2.2 Simulations Plus Main Business
        9.2.3 Simulations Plus Pharmacokinetics Software Products, Services and Solutions
        9.2.4 Simulations Plus Pharmacokinetics Software Revenue (US$ Million) & (2020-2025)
        9.2.5 Simulations Plus Recent Developments
    9.3 IntiQuan GmbH
        9.3.1 IntiQuan GmbH Profile
        9.3.2 IntiQuan GmbH Main Business
        9.3.3 IntiQuan GmbH Pharmacokinetics Software Products, Services and Solutions
        9.3.4 IntiQuan GmbH Pharmacokinetics Software Revenue (US$ Million) & (2020-2025)
        9.3.5 IntiQuan GmbH Recent Developments
    9.4 Bayer
        9.4.1 Bayer Profile
        9.4.2 Bayer Main Business
        9.4.3 Bayer Pharmacokinetics Software Products, Services and Solutions
        9.4.4 Bayer Pharmacokinetics Software Revenue (US$ Million) & (2020-2025)
        9.4.5 Bayer Recent Developments
    9.5 Genedata AG
        9.5.1 Genedata AG Profile
        9.5.2 Genedata AG Main Business
        9.5.3 Genedata AG Pharmacokinetics Software Products, Services and Solutions
        9.5.4 Genedata AG Pharmacokinetics Software Revenue (US$ Million) & (2020-2025)
        9.5.5 Genedata AG Recent Developments
    9.6 Thermo Scientific
        9.6.1 Thermo Scientific Profile
        9.6.2 Thermo Scientific Main Business
        9.6.3 Thermo Scientific Pharmacokinetics Software Products, Services and Solutions
        9.6.4 Thermo Scientific Pharmacokinetics Software Revenue (US$ Million) & (2020-2025)
        9.6.5 Thermo Scientific Recent Developments
    9.7 SGS
        9.7.1 SGS Profile
        9.7.2 SGS Main Business
        9.7.3 SGS Pharmacokinetics Software Products, Services and Solutions
        9.7.4 SGS Pharmacokinetics Software Revenue (US$ Million) & (2020-2025)
        9.7.5 SGS Recent Developments
    9.8 Pharmaron
        9.8.1 Pharmaron Profile
        9.8.2 Pharmaron Main Business
        9.8.3 Pharmaron Pharmacokinetics Software Products, Services and Solutions
        9.8.4 Pharmaron Pharmacokinetics Software Revenue (US$ Million) & (2020-2025)
        9.8.5 Pharmaron Recent Developments
    9.9 Pumas-AI
        9.9.1 Pumas-AI Profile
        9.9.2 Pumas-AI Main Business
        9.9.3 Pumas-AI Pharmacokinetics Software Products, Services and Solutions
        9.9.4 Pumas-AI Pharmacokinetics Software Revenue (US$ Million) & (2020-2025)
        9.9.5 Pumas-AI Recent Developments
    9.10 PharmoGo
        9.10.1 PharmoGo Profile
        9.10.2 PharmoGo Main Business
        9.10.3 PharmoGo Pharmacokinetics Software Products, Services and Solutions
        9.10.4 PharmoGo Pharmacokinetics Software Revenue (US$ Million) & (2020-2025)
        9.10.5 PharmoGo Recent Developments
    9.11 Chuangteng Technology
        9.11.1 Chuangteng Technology Profile
        9.11.2 Chuangteng Technology Main Business
        9.11.3 Chuangteng Technology Pharmacokinetics Software Products, Services and Solutions
        9.11.4 Chuangteng Technology Pharmacokinetics Software Revenue (US$ Million) & (2020-2025)
        9.11.5 Chuangteng Technology Recent Developments
    9.12 Medixi Biomedical
        9.12.1 Medixi Biomedical Profile
        9.12.2 Medixi Biomedical Main Business
        9.12.3 Medixi Biomedical Pharmacokinetics Software Products, Services and Solutions
        9.12.4 Medixi Biomedical Pharmacokinetics Software Revenue (US$ Million) & (2020-2025)
        9.12.5 Medixi Biomedical Recent Developments

10 Industry Chain Analysis
    10.1 Pharmacokinetics Software Industrial Chain
    10.2 Pharmacokinetics Software Upstream Analysis
        10.2.1 Key Raw Materials
        10.2.2 Raw Materials Key Suppliers
        10.2.3 Manufacturing Cost Structure
    10.3 Midstream Analysis
    10.4 Downstream Analysis (Customers Analysis)
    10.5 Sales Model and Sales Channels
        10.5.1 Pharmacokinetics Software Sales Model
        10.5.2 Sales Channel
        10.5.3 Pharmacokinetics Software Distributors

11 Research Findings and Conclusion

12 Appendix
    12.1 Research Methodology
        12.1.1 Methodology/Research Approach
            12.1.1.1 Research Programs/Design
            12.1.1.2 Market Size Estimation
            12.1.1.3 Market Breakdown and Data Triangulation
        12.1.2 Data Source
            12.1.2.1 Secondary Sources
            12.1.2.2 Primary Sources
    12.2 Author Details
    12.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Pharmacokinetics Software Market Trends
 Table 2. Pharmacokinetics Software Market Drivers & Opportunity
 Table 3. Pharmacokinetics Software Market Challenges
 Table 4. Pharmacokinetics Software Market Restraints
 Table 5. Global Pharmacokinetics Software Revenue by Company (2020-2025) & (US$ Million)
 Table 6. Global Pharmacokinetics Software Revenue Market Share by Company (2020-2025)
 Table 7. Key Companies Pharmacokinetics Software Manufacturing Base Distribution and Headquarters
 Table 8. Key Companies Pharmacokinetics Software Product Type
 Table 9. Key Companies Time to Begin Mass Production of Pharmacokinetics Software
 Table 10. Global Pharmacokinetics Software Companies Market Concentration Ratio (CR5 and HHI)
 Table 11. Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmacokinetics Software as of 2024)
 Table 12. Mergers & Acquisitions, Expansion Plans
 Table 13. Global Pharmacokinetics Software Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
 Table 14. Global Pharmacokinetics Software Sales Value by Type (2020-2025) & (US$ Million)
 Table 15. Global Pharmacokinetics Software Sales Value by Type (2026-2031) & (US$ Million)
 Table 16. Global Pharmacokinetics Software Sales Market Share in Value by Type (2020-2025)
 Table 17. Global Pharmacokinetics Software Sales Market Share in Value by Type (2026-2031)
 Table 18. Global Pharmacokinetics Software Sales Value by Scene: 2020 VS 2024 VS 2031 (US$ Million)
 Table 19. Global Pharmacokinetics Software Sales Value by Scene (2020-2025) & (US$ Million)
 Table 20. Global Pharmacokinetics Software Sales Value by Scene (2026-2031) & (US$ Million)
 Table 21. Global Pharmacokinetics Software Sales Market Share in Value by Scene (2020-2025)
 Table 22. Global Pharmacokinetics Software Sales Market Share in Value by Scene (2026-2031)
 Table 23. Global Pharmacokinetics Software Sales Value by Deployment: 2020 VS 2024 VS 2031 (US$ Million)
 Table 24. Global Pharmacokinetics Software Sales Value by Deployment (2020-2025) & (US$ Million)
 Table 25. Global Pharmacokinetics Software Sales Value by Deployment (2026-2031) & (US$ Million)
 Table 26. Global Pharmacokinetics Software Sales Market Share in Value by Deployment (2020-2025)
 Table 27. Global Pharmacokinetics Software Sales Market Share in Value by Deployment (2026-2031)
 Table 28. Global Pharmacokinetics Software Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
 Table 29. Global Pharmacokinetics Software Sales Value by Application (2020-2025) & (US$ Million)
 Table 30. Global Pharmacokinetics Software Sales Value by Application (2026-2031) & (US$ Million)
 Table 31. Global Pharmacokinetics Software Sales Market Share in Value by Application (2020-2025)
 Table 32. Global Pharmacokinetics Software Sales Market Share in Value by Application (2026-2031)
 Table 33. Global Pharmacokinetics Software Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
 Table 34. Global Pharmacokinetics Software Sales Value by Region (2020-2025) & (US$ Million)
 Table 35. Global Pharmacokinetics Software Sales Value by Region (2026-2031) & (US$ Million)
 Table 36. Global Pharmacokinetics Software Sales Value by Region (2020-2025) & (%)
 Table 37. Global Pharmacokinetics Software Sales Value by Region (2026-2031) & (%)
 Table 38. Key Countries/Regions Pharmacokinetics Software Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Key Countries/Regions Pharmacokinetics Software Sales Value, (2020-2025) & (US$ Million)
 Table 40. Key Countries/Regions Pharmacokinetics Software Sales Value, (2026-2031) & (US$ Million)
 Table 41. Certara Basic Information List
 Table 42. Certara Description and Business Overview
 Table 43. Certara Pharmacokinetics Software Products, Services and Solutions
 Table 44. Revenue (US$ Million) in Pharmacokinetics Software Business of Certara (2020-2025)
 Table 45. Certara Recent Developments
 Table 46. Simulations Plus Basic Information List
 Table 47. Simulations Plus Description and Business Overview
 Table 48. Simulations Plus Pharmacokinetics Software Products, Services and Solutions
 Table 49. Revenue (US$ Million) in Pharmacokinetics Software Business of Simulations Plus (2020-2025)
 Table 50. Simulations Plus Recent Developments
 Table 51. IntiQuan GmbH Basic Information List
 Table 52. IntiQuan GmbH Description and Business Overview
 Table 53. IntiQuan GmbH Pharmacokinetics Software Products, Services and Solutions
 Table 54. Revenue (US$ Million) in Pharmacokinetics Software Business of IntiQuan GmbH (2020-2025)
 Table 55. IntiQuan GmbH Recent Developments
 Table 56. Bayer Basic Information List
 Table 57. Bayer Description and Business Overview
 Table 58. Bayer Pharmacokinetics Software Products, Services and Solutions
 Table 59. Revenue (US$ Million) in Pharmacokinetics Software Business of Bayer (2020-2025)
 Table 60. Bayer Recent Developments
 Table 61. Genedata AG Basic Information List
 Table 62. Genedata AG Description and Business Overview
 Table 63. Genedata AG Pharmacokinetics Software Products, Services and Solutions
 Table 64. Revenue (US$ Million) in Pharmacokinetics Software Business of Genedata AG (2020-2025)
 Table 65. Genedata AG Recent Developments
 Table 66. Thermo Scientific Basic Information List
 Table 67. Thermo Scientific Description and Business Overview
 Table 68. Thermo Scientific Pharmacokinetics Software Products, Services and Solutions
 Table 69. Revenue (US$ Million) in Pharmacokinetics Software Business of Thermo Scientific (2020-2025)
 Table 70. Thermo Scientific Recent Developments
 Table 71. SGS Basic Information List
 Table 72. SGS Description and Business Overview
 Table 73. SGS Pharmacokinetics Software Products, Services and Solutions
 Table 74. Revenue (US$ Million) in Pharmacokinetics Software Business of SGS (2020-2025)
 Table 75. SGS Recent Developments
 Table 76. Pharmaron Basic Information List
 Table 77. Pharmaron Description and Business Overview
 Table 78. Pharmaron Pharmacokinetics Software Products, Services and Solutions
 Table 79. Revenue (US$ Million) in Pharmacokinetics Software Business of Pharmaron (2020-2025)
 Table 80. Pharmaron Recent Developments
 Table 81. Pumas-AI Basic Information List
 Table 82. Pumas-AI Description and Business Overview
 Table 83. Pumas-AI Pharmacokinetics Software Products, Services and Solutions
 Table 84. Revenue (US$ Million) in Pharmacokinetics Software Business of Pumas-AI (2020-2025)
 Table 85. Pumas-AI Recent Developments
 Table 86. PharmoGo Basic Information List
 Table 87. PharmoGo Description and Business Overview
 Table 88. PharmoGo Pharmacokinetics Software Products, Services and Solutions
 Table 89. Revenue (US$ Million) in Pharmacokinetics Software Business of PharmoGo (2020-2025)
 Table 90. PharmoGo Recent Developments
 Table 91. Chuangteng Technology Basic Information List
 Table 92. Chuangteng Technology Description and Business Overview
 Table 93. Chuangteng Technology Pharmacokinetics Software Products, Services and Solutions
 Table 94. Revenue (US$ Million) in Pharmacokinetics Software Business of Chuangteng Technology (2020-2025)
 Table 95. Chuangteng Technology Recent Developments
 Table 96. Medixi Biomedical Basic Information List
 Table 97. Medixi Biomedical Description and Business Overview
 Table 98. Medixi Biomedical Pharmacokinetics Software Products, Services and Solutions
 Table 99. Revenue (US$ Million) in Pharmacokinetics Software Business of Medixi Biomedical (2020-2025)
 Table 100. Medixi Biomedical Recent Developments
 Table 101. Key Raw Materials Lists
 Table 102. Raw Materials Key Suppliers Lists
 Table 103. Pharmacokinetics Software Downstream Customers
 Table 104. Pharmacokinetics Software Distributors List
 Table 105. Research Programs/Design for This Report
 Table 106. Key Data Information from Secondary Sources
 Table 107. Key Data Information from Primary Sources


List of Figures
 Figure 1. Pharmacokinetics Software Product Picture
 Figure 2. Global Pharmacokinetics Software Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Global Pharmacokinetics Software Sales Value (2020-2031) & (US$ Million)
 Figure 4. Pharmacokinetics Software Report Years Considered
 Figure 5. Global Pharmacokinetics Software Players Revenue Ranking (2024) & (US$ Million)
 Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Pharmacokinetics Software Revenue in 2024
 Figure 7. Pharmacokinetics Software Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 8. Compartmental Model Picture
 Figure 9. Non-Compartmental Models Picture
 Figure 10. Global Pharmacokinetics Software Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
 Figure 11. Global Pharmacokinetics Software Sales Value Market Share by Type, 2024 & 2031
 Figure 12. Drug Development Picture
 Figure 13. Clinical Picture
 Figure 14. Academic Teaching Picture
 Figure 15. Global Pharmacokinetics Software Sales Value by Scene (2020 VS 2024 VS 2031) & (US$ Million)
 Figure 16. Global Pharmacokinetics Software Sales Value Market Share by Scene, 2024 & 2031
 Figure 17. Cloud-Based Picture
 Figure 18. On-premises Picture
 Figure 19. Global Pharmacokinetics Software Sales Value by Deployment (2020 VS 2024 VS 2031) & (US$ Million)
 Figure 20. Global Pharmacokinetics Software Sales Value Market Share by Deployment, 2024 & 2031
 Figure 21. Product Picture of Experimental Design
 Figure 22. Product Picture of Clinical Pharmacokinetics
 Figure 23. Product Picture of Other
 Figure 24. Global Pharmacokinetics Software Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
 Figure 25. Global Pharmacokinetics Software Sales Value Market Share by Application, 2024 & 2031
 Figure 26. North America Pharmacokinetics Software Sales Value (2020-2031) & (US$ Million)
 Figure 27. North America Pharmacokinetics Software Sales Value by Country (%), 2024 VS 2031
 Figure 28. Europe Pharmacokinetics Software Sales Value, (2020-2031) & (US$ Million)
 Figure 29. Europe Pharmacokinetics Software Sales Value by Country (%), 2024 VS 2031
 Figure 30. Asia Pacific Pharmacokinetics Software Sales Value, (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Pharmacokinetics Software Sales Value by Region (%), 2024 VS 2031
 Figure 32. South America Pharmacokinetics Software Sales Value, (2020-2031) & (US$ Million)
 Figure 33. South America Pharmacokinetics Software Sales Value by Country (%), 2024 VS 2031
 Figure 34. Middle East & Africa Pharmacokinetics Software Sales Value, (2020-2031) & (US$ Million)
 Figure 35. Middle East & Africa Pharmacokinetics Software Sales Value by Country (%), 2024 VS 2031
 Figure 36. Key Countries/Regions Pharmacokinetics Software Sales Value (%), (2020-2031)
 Figure 37. United States Pharmacokinetics Software Sales Value, (2020-2031) & (US$ Million)
 Figure 38. United States Pharmacokinetics Software Sales Value by Type (%), 2024 VS 2031
 Figure 39. United States Pharmacokinetics Software Sales Value by Application (%), 2024 VS 2031
 Figure 40. Europe Pharmacokinetics Software Sales Value, (2020-2031) & (US$ Million)
 Figure 41. Europe Pharmacokinetics Software Sales Value by Type (%), 2024 VS 2031
 Figure 42. Europe Pharmacokinetics Software Sales Value by Application (%), 2024 VS 2031
 Figure 43. China Pharmacokinetics Software Sales Value, (2020-2031) & (US$ Million)
 Figure 44. China Pharmacokinetics Software Sales Value by Type (%), 2024 VS 2031
 Figure 45. China Pharmacokinetics Software Sales Value by Application (%), 2024 VS 2031
 Figure 46. Japan Pharmacokinetics Software Sales Value, (2020-2031) & (US$ Million)
 Figure 47. Japan Pharmacokinetics Software Sales Value by Type (%), 2024 VS 2031
 Figure 48. Japan Pharmacokinetics Software Sales Value by Application (%), 2024 VS 2031
 Figure 49. South Korea Pharmacokinetics Software Sales Value, (2020-2031) & (US$ Million)
 Figure 50. South Korea Pharmacokinetics Software Sales Value by Type (%), 2024 VS 2031
 Figure 51. South Korea Pharmacokinetics Software Sales Value by Application (%), 2024 VS 2031
 Figure 52. Southeast Asia Pharmacokinetics Software Sales Value, (2020-2031) & (US$ Million)
 Figure 53. Southeast Asia Pharmacokinetics Software Sales Value by Type (%), 2024 VS 2031
 Figure 54. Southeast Asia Pharmacokinetics Software Sales Value by Application (%), 2024 VS 2031
 Figure 55. India Pharmacokinetics Software Sales Value, (2020-2031) & (US$ Million)
 Figure 56. India Pharmacokinetics Software Sales Value by Type (%), 2024 VS 2031
 Figure 57. India Pharmacokinetics Software Sales Value by Application (%), 2024 VS 2031
 Figure 58. Pharmacokinetics Software Industrial Chain
 Figure 59. Pharmacokinetics Software Manufacturing Cost Structure
 Figure 60. Channels of Distribution (Direct Sales, and Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed

Description

The global market for Pharmacokinetics Software was estimated to be worth US$ 476 million in 2024 and is forecast to a readjusted size of US$ 846 million by 2031 with a CAGR of 8.2% during the forecast period 2025-2031.

Pharmacokinetics Software is a type of professional software developed based on pharmacokinetic theory and computer algorithms. It is specifically used to process data related to the absorption, distribution, metabolism and excretion of drugs in organisms, and to realize functions such as parameter calculation, model building and process simulation. It provides data support and decision-making basis for drug development, clinical trials and personalized medicine.

North America still dominates the global market, but the Asia-Pacific market is emerging at a faster growth rate. In 2023, North America was the largest revenue market in the field of pharmacokinetic computational biology, and in the life sciences software market, North America accounted for 42% of the market share in 2024, thanks to its mature innovative drug development system and the strong demand from numerous CRO companies.

Policy adjustments by global regulatory agencies are continuously reshaping the development direction of pharmacokinetic software. The FDA's updated guidance in 2023 explicitly requires innovative drug applications to include physiologically based pharmacokinetic (PBPK) model data, and the EMA plans to implement an electronic submission system for ePK files by 2026. These policies are compelling pharmaceutical companies to adopt software with stronger compliance and better data management capabilities.

This report aims to provide a comprehensive presentation of the global market for Pharmacokinetics Software, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Pharmacokinetics Software by region & country, by Type, and by Application.

The Pharmacokinetics Software market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmacokinetics Software.

Market Segmentation

Related Reports

Global Pharmacokinetics Software Market Research Report 2024
The global Pharmacokinetics Software market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-18
Pages: 85
USD 2900.00
(Single User License)
Global Pharmacokinetics Software Market Insights, Forecast to 2030
Market Analysis and Insights: Global Pharmacokinetics Software Market
Published: 2024-04-26
Pages: 112
USD 4900.00
(Single User License)
Global Pharmacokinetics Software Market Research Report 2025
The global market for Pharmacokinetics Software was valued at US$ 476 million in the year 2024 and is projected to reach a revised size of US$ 846 million by 2031, growing at a CAGR of 8.2% during the forecast period.
Published: 2025-11-27
Pages: 84
USD 2900.00
(Single User License)
Pharmacokinetics Software- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Pharmacokinetics Software was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-03
Pages: 106
USD 3950.00
(Single User License)
Global Pharmacokinetics Software Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Pharmacokinetics Software market size was US$ 476 million in 2024 and is forecast to a readjusted size of US$ 846 million by 2031 with a CAGR of 8.2% during the forecast period 2025-2031.
Published: 2025-11-27
Pages: 93
USD 4250.00
(Single User License)
Global Pharmacokinetics Software Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Pharmacokinetics Software market is projected to grow from US$ 476 million in 2024 to US$ 846 million by 2031, at a CAGR of 8.2% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-11-27
Pages: 143
USD 4900.00
(Single User License)
Global Pharmacokinetics Software Market Research Report 2026
The global Pharmacokinetics Software market was valued at US$ 529 million in 2025 and is anticipated to reach US$ 909 million by 2032, at a CAGR of 8.2% from 2026 to 2032.
Published: 2026-02-11
Pages: 116
USD 2900.00
(Single User License)
Pharmacokinetics Software - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Pharmacokinetics Software was estimated to be worth US$ 529 million in 2025 and is projected to reach US$ 909 million, growing at a CAGR of 8.2% from 2026 to 2032.
Published: 2026-02-11
Pages: 106
USD 3950.00
(Single User License)

Global Pharmacokinetics Software Market Research Report 2024
The global Pharmacokinetics Software market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-18
Pages: 85
USD 2900.00 ()
Global Pharmacokinetics Software Market Insights, Forecast to 2030
Market Analysis and Insights: Global Pharmacokinetics Software Market
Published: 2024-04-26
Pages: 112
USD 4900.00 ()
Global Pharmacokinetics Software Market Research Report 2025
The global market for Pharmacokinetics Software was valued at US$ 476 million in the year 2024 and is projected to reach a revised size of US$ 846 million by 2031, growing at a CAGR of 8.2% during the forecast period.
Published: 2025-11-27
Pages: 84
USD 2900.00 ()
Pharmacokinetics Software- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Pharmacokinetics Software was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-03
Pages: 106
USD 3950.00 ()
Global Pharmacokinetics Software Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Pharmacokinetics Software market size was US$ 476 million in 2024 and is forecast to a readjusted size of US$ 846 million by 2031 with a CAGR of 8.2% during the forecast period 2025-2031.
Published: 2025-11-27
Pages: 93
USD 4250.00 ()
Global Pharmacokinetics Software Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Pharmacokinetics Software market is projected to grow from US$ 476 million in 2024 to US$ 846 million by 2031, at a CAGR of 8.2% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-11-27
Pages: 143
USD 4900.00 ()
Global Pharmacokinetics Software Market Research Report 2026
The global Pharmacokinetics Software market was valued at US$ 529 million in 2025 and is anticipated to reach US$ 909 million by 2032, at a CAGR of 8.2% from 2026 to 2032.
Published: 2026-02-11
Pages: 116
USD 2900.00 ()
Pharmacokinetics Software - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Pharmacokinetics Software was estimated to be worth US$ 529 million in 2025 and is projected to reach US$ 909 million, growing at a CAGR of 8.2% from 2026 to 2032.
Published: 2026-02-11
Pages: 106
USD 3950.00 ()